/ Medical Professionals

Medicines

Genentech has multiple products on the market for serious or life-threatening medical conditions. Access information and resources on each of our medicines below.

Prescribing Information

Medication Guide

Healthcare Provider Letter

Material Safety Data Sheets

Biooncology
Avastin® (bevacizumab)
Healthcare Provider Letters: Intraocular Inflammatory Reactions - Dec 2008 Warning for Counterfeit Product Labeled as Avastin in the United States Feb 2012 Important Drug Warning: Necrotizing Fasciitis - Apr 2013 Important New Safety Information in Women Receiving AVASTIN - Oct 2011 Microangiopathic Hemolytic Anemia (MAHA) - July 2008 Cases of RPLS in Patients Receiving AVASTIN - Sept 2006 Tracheoesophageal (TE) Fistula - April 2007 VEGF antibodies for the treatment of retinopathy of prematurity - Aug 2006 Important Change to Avastin® label for treatment of metastatic breast cancer - Nov 2011
Erivedge® (vismodegib)
Herceptin® (trastuzumab)
Healthcare Provider Letters: Updated Cardiotoxicity Information - Aug 2005 440mg Vials and Herceptin BWFI Diluent - June 2008 Fatal Embryo-Fetal Toxicity due to Herceptin Exposure During Pregnancy
Kadcyla™ (ado-trastuzumab emtansine)
Perjeta® (pertuzumab)
Rituxan® (rituximab-BioOncology)
Healthcare Provider Letters: Important Drug Warning: New Safety Information - Sept 2008 Important Drug Warning: Updated Safety Information - Oct 2009 Important Drug Warning: Updated Safety Information - Dec 2006
Tarceva® (erlotinib)
Xeloda® (capecitabine)
Zelboraf® (vemurafenib)

Immunology and Ophthalmology
Actemra® (tocilizumab)
Healthcare Provider Letters: Actemra for RA and SJIA - Oct 2012 Actemra for RA and SJIA - June 2011
Lucentis™ (ranibizumab injection)
Healthcare Provider Letters: SAILOR with AMD - Jan 2007 Important Drug Notification: Intraocular Inﬂammatory Reactions After Intravitreal Injection - Dec 2008 Safety Risk with Intravitreal Use of VEGF - Aug 2006
Rituxan® (rituximab - Immunology)
Healthcare Provider Letters: Rituxan and the treatment of SLE - Dec 2006 Rituxan and PML - Oct 2009 Rituxan and RA - Sept 2008
Xolair® (omalizumab)

Metabolism & Primary Care
Activase® (alteplase)
Cathflo Activase® (alteplase)
Nutropin AQ® (somatropin (rDNA origin) for injection)
Healthcare Provider Letters: Counterfeit Drug Warning - Aug 2001 Safety Information Regarding Alcohol Prep Pads - Jan 2011 Counterfeit Growth Hormone Investigation - Nov 2001
TNKase® (tenecteplase)

Virology & Specialty Care
CellCept® (mycophenolate mofetil)
Healthcare Provider Letters: Mycophenolate REMS (Risk Evaluation and Mitigation Strategy) - 2012 Reports of Pure Red Cell Aplasia - Aug 2009 Pregnancy Notice - 2010 Pharmacists: Important New Dispensing Information - Jan 2009 Introduction of a CellCept Medication Guide - Jan 2009 Important Changes in the CellCept® Prescribing Information - Oct 2007 Important Changes in the CellCept® Prescribing Information - June 2008
Pegasys® (peginterferon alfa-2a)
Healthcare Provider Letters: Potential Supply Constraint with PEGASYS® - March 2012 Updates Package Inserts - Jan 2008 New Med Guide for Pre-Filled Syringes - Jan 2009 Vials Packaging Change - Jan 2009 Vials Packaging Change - Aug 2006 Potential Supply Constraint with PEGASYS® - March 2012
Pulmozyme® (dornase alfa)
Tamiflu® (oseltamivir phosphate)
Valcyte® (valganciclovir hydrochloride)

Other Products
Anaprox® (naproxen sodium)
Boniva Injection® (ibandronate sodium)
Healthcare Provider Letters: New NDC for 3mg Injection - Aug 2011 Safety Information Concerning Infusion Set - Oct 2012
Boniva Tablets® (ibandronate sodium)
Cytovene® (ganciclovir)
EC-Naprosyn® (naproxen)
Fuzeon® (enfuvirtide)
Healthcare Provider Letters: Supplier Change for Sterile Water Vials - Aug 2011 Shipping Label Change - April 2008
Invirase® (saquinavir mesylate)
Healthcare Provider Letters: Pediatric Use and Potential for QT and PR Interval Prolongation - Feb 2013 Update to Package Insert - Feb 2008 Discontinue Soft-Gel Formulation of Saquinavir - May 2005 QT and PR Potential Drug Interactions - Nov 2010
Klonopin® (clonazepam)
Healthcare Provider Letters: Supply Shortage of Wafers - Feb 2008 Supply Shortage of Wafers - March 2009 Short Dated Supply - Nov 2007
Kytril Injection™ (granisetron HCL)
Healthcare Provider Letters: Kytril product deletions - Oct 2009 Supply shortage of Kytril oral solution - May 2007 Packaging change of Kytril, single use vial 1ml - Sept 2006 Supply shortage of Kytril, single use vial 1ml - Jan 2008 Ktytril 1mg/1mL 4mL MULTI-DOSE VIAL - Sept 2008 Packaging change Kytril 4ml multi dose vial - Sept 2006 Discontinued Kytril oral solution - Nov 2007 Short dated supply situation of Kytril 1ml single use vial - Sept 2007 Supply shortage of Kytril, single use vial 1ml - April 2008 Short dated supply of Kytril oral solution - Dec 2006
Kytril Tablets® (ganisetron HCL)
Naprosyn® (naproxen)
Rocephin® (ceftriaxone)
Healthcare Provider Letters: Supply Shortage - Oct 2006 Discontinued 2g Vials - Sept 2008 Supply Shortage 500mg Vials - Sept 2007 Supply Shortage 2gm Vials - Feb 2008 Discontinued 250mg Vials - Sept 2008 Packaging and Vial Size Change - Aug 2006
Roferon-A® (interferon alfa-2a)
Romazicon® (flumazenil)
Valium ® (diazepam)
Xenical® (orlistat)
Healthcare Provider Letters: Patient Information - Jan 2012 Severe Liver Injury - Sept 2010 Capsule Color Change - Aug 2011 Contraindication in Pregnancy - May 2012
Zenapax® (daclizumab)

The Art of Science

Bob Cohen describes how he began researching new treatment options for cancer patients.

Medicines

You Might Also Be Interested In

The Art of Science